A form of cross-validation in which more than one observation is left out at each run. Typically many runs with random samplings are performed.
Source: PAC, 2016,
88, 239. (
Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015)) on page 249 [
Terms] [
Paper]